Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Children’s Cancer Institute enhances delivery of research with Yellowfin Business Intelligence platform
  • USA - English


News provided by

Yellowfin

Aug 18, 2016, 06:00 ET

Share this article

Share toX

Share this article

Share toX

Yellowfin: Making Business Intelligence easy
Yellowfin: Making Business Intelligence easy

(PRWEB) August 18, 2016 -- In 2015, the Institute and Sydney Children’s Hospitals Network announced Zero Childhood Cancer – a national personalized medicine program to identify tailored treatments for children with high risk cancer. The Zero Childhood Cancer Program increased the need for the Institute’s operational data to be highly accessible to users as it scaled-up, with Yellowfin reports helping to enable that accessibility.

Yellowfin’s ability to easily connect to a wide range of data sources, and present dashboards to the user that have a consistent look and feel, meant it could be embraced by the entire Institute

Post this

“Yellowfin is supporting the back-end operations that have hugely increased demands placed on them during the pilot of the national personalized medicine program,” said the Institute’s Head of Technology, Elaine Neeson. “Our fundraising operations, set on raising $50M for the full national program to 2020, are especially benefiting from the improved tracking and reporting Yellowfin provides.

“This all goes towards improving the lives and survival rates of childhood cancer sufferers – the very reason every Children’s Cancer Institute employee comes into work each day.”

“As the only independent medical institute in Australia solely dedicated to researching cures for childhood cancer, Yellowfin is proud to help Children’s Cancer Institute enhance its world-leading work regarding the causes, prevention and treatments of cancer,” said Yellowfin VP Strategy and Corporate Development, Martyn Reeves. “Yellowfin is delighted to be able to provide special licensing discounts that assist not-for-profit organizations to access world-class analytics software and improve the vital services they offer by making data-driven decisions.”

Deploying Yellowfin has also enabled researchers and business users to quickly and independently analyze, share and act on a unified view of their operational data, allowing the Institute to improve effectiveness and efficiency throughout the organization.

“The previous method of reporting involved a combination of basic SQL Reporting Services reports, spreadsheets and application-specific reporting tools,” said Business Systems & Information Manager, Tracy Hogg. “In some cases, functionality was simply unavailable, with business unit staff [including HR, finance and fundraising] as well as research managers unable to generate the reports and consequent insights required.”

The Institute identified that it required a database-independent tool to combine reporting from multiple disparate sources, in order to produce reports offering insights across the research, operational and business aspects of the organization.

“We needed a Business Intelligence and analytics tool that would talk to the many applications and databases we need in order to support our research and run our business,” said Hogg. “Yellowfin’s simple, intuitive ‘out-of-the-box’ design and layout was a driving factor when compared with other platforms available.”

The Yellowfin platform has enabled Children’s Cancer Institute to quickly deliver consistent reporting, data analysis and deeper insights throughout the Institute, including the research teams, finance department, marketing and fundraising teams, as well as executive management.

“Yellowfin has delivered beyond expectations and has proven instrumental in boosting the efficiency and improving the effectiveness of researchers and business users alike,” said Hogg. “Yellowfin’s ability to easily connect to a wide range of data sources, and present dashboards to the user that have a consistent look and feel, meant it could be embraced by the entire Institute.”

Metrics being analyzed and reports generated span many facets of the Institute, including human resources leave balances, ethics reporting, fundraising trends and analysis, as well as budgeting and finance reporting.

According to Neeson, not only did Yellowfin improve the Institute’s reporting environment, it also “opened its eyes” to new possibilities for additional reporting, as well as the reality of the Institute’s data.

“Yellowfin has enabled the team to amend processes to boost efficiency, pinpoint trends and focus on required improvements,” said Neeson. “All this has been possible because users can simply click a button to view a report, rather than spending that time creating the report itself.

“Yellowfin makes it possible to design and build useful reporting solutions, which add real value to the business, in hours rather than weeks. It has enabled us to track and monitor key metrics in real-time, which were previously only available by monthly reports, or not at all.”

Children’s Cancer Institute is the only independent medical institute in Australia solely dedicated to research regarding the causes, prevention, treatments and cures for childhood cancer.

  • ENDS -

About Children’s Cancer Institute

Children’s Cancer Institute is the only independent medical research organization in Australia dedicated 100 percent to childhood cancer research, existing solely to cure childhood cancer and improve the quality of life for survivors. The Institute was originally known as The Children's Leukaemia and Cancer Foundation and was established in May 1976 by a dedicated group of parents and doctors of children with cancer. Children's Cancer Institute opened its own research laboratories in 1984 and has since grown to employ nearly 200 staff and students, establishing a national and international reputation for scientific excellence.

Children’s Cancer Institute relies on grants and community support to complete our work. Every dollar we receive from government and granting bodies to support direct research costs must be matched with a dollar raised by the community through partnerships, donations and fundraising to cover the indirect costs of our work. We are constantly under pressure to raise more funds as our research portfolio expands. Without dedicated funding and the help of our supporters – which include community fundraisers, corporate partners, individual donors, supporters and volunteers – we’re unable to complete the vital research we know will uncover a cure for childhood cancer.

About Yellowfin

Yellowfin is a global Business Intelligence (BI) and analytics software vendor passionate about making BI easy. Founded in 2003 in response to the complexity and costs associated with implementing and using traditional BI tools, Yellowfin is a highly intuitive 100 percent Web-based reporting and analytics solution. Yellowfin is a leader in mobile, collaborative and embedded BI, as well as Location Intelligence and data visualization.

Over 10,000 organizations, and more than 2 million end-users across 70 different countries, use Yellowfin every day. For more information, visit http://www.yellowfinbi.com

For regular news and updates, follow Yellowfin on Twitter (@YellowfinBI), LinkedIn (Yellowfin Business Intelligence), YouTube (Yellowfin Team) or email pr(at)yellowfin(dot)bi to subscribe to Yellowfin’s free e-newsletter.

For further media information, interviews, images or product demonstration, please contact:

Lachlan James, Yellowfin Global Communications Manager on +61 (0)3 8617 4954, +61 (0)431 835 658 or lachlan.james(at)yellowfin(dot)bi

Lachlan James, Yellowfin, http://www.yellowfinbi.com, +61 386174954, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.